Contractors / Alvogen, Inc.
Alvogen, Inc.
prime recipient of federal awards · UEI LJNNGDV77Y98 ✓ from source
$227.7M
obligated · FY2025
3
funding agencies
100%
from Health and Hum…
0%
single-source
1
states
100%
in New Jersey
2
industries
≈ computedSingle-source: 0% of this recipient’s $227.7M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.
Where this money comes from
✓ from sourceFUNDING AGENCIES
ALVOGEN, INC.
HHS
$0.2B
2 other agencies
$0B
Alvogen, Inc.
$0.2B
FY2025 obligated
Biggest awards (total value)
Total value over each award’s life, for awards active in FY2025: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
New Jersey✓ from source$227.7M
Competitors
Mckesson Corporation≈ computed$11.9B
Sanofi Vaccines US Inc.≈ computed$1B
Glaxosmithkline, LLC≈ computed$958.8M
Pfizer Inc≈ computed$700.6M
Bavarian Nordic A/S≈ computed$143.6M
DMS Pharmaceutical Group Inc≈ computed$4.3M
Baylor College of Medicine≈ computed$3.1M
Trillamed LLC≈ computed$1.5M
computed from shared NAICS, not a stated rivalry.
Corporate family
Single registration: no combined family.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.